Company:Vaccitech
 | |
| Type | Public |
|---|---|
| NASDAQ: VACC | |
| Industry | Vaccines Immunotherapy Biotechnology |
| Founded | 2016 |
| Founder |
|
| Headquarters | Oxford Science Park, Oxford , |
| Website | vaccitech |
Vaccitech plc is a biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, such as hepatitis B, HPV and prostate cancer.[1][2]
Technology
The company's platform includes Chimpanzee Adenovirus Oxford (ChAdOx) and Modified Vaccinia Ankara (MVA), two viral vectors which safely mimic viral infection in human cells and elicit antibody and T cell responses to pathogens and tumours.[3]
History
The company was founded in 2016 as a University spin-off by Sarah Gilbert and Adrian V. S. Hill at The Jenner Institute, University of Oxford.[4][5][6]
Vaccitech has been financed and supported by Google Ventures (GV), Sequoia Capital, GeneMatrix, Liontrust Asset Management, Korea Investment Partners and Oxford Sciences Innovation (OSI).[7]
In early 2020, Vaccitech and the University of Oxford co-invented a vaccine for COVID-19 using the ChAdOx platform.
COVID-19 vaccine
In July 2020, it was reported that people in Brazil, South Africa and the US had been recruited to populate the vaccine trials.[8]
In July 2020, Vaccitech scientists reported in The Lancet a "single-blind, randomised controlled trial in five trial sites in the UK of a chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19) expressing the SARS-CoV-2 spike protein." Several subjects needed prophylactic paracetamol to minimize their adverse reactions.
References
- ↑ {{Twitter}} template missing ID and not present in Wikidata.
- ↑ Anon (2016). "Vaccitech Limited". London: Companies House. https://beta.companieshouse.gov.uk/company/09973585.
- ↑ Anon (2019). "Vaccitech - Creating ways to treat and prevent disease". Vaccitech Limited. https://www.vaccitech.co.uk/.
- ↑ Anon (2019). "Vaccitech Ltd.". Bloomberg News. https://www.bloomberg.com/profile/company/1570525D:LN.
- ↑ Anon (2016). "Universal flu vaccine under development by Oxford spinout Vaccitech". University of Oxford. http://www.ox.ac.uk/news/2016-05-12-universal-flu-vaccine-under-development-oxford-spinout-vaccitech.
- ↑ Anon (2019). "Vaccitech secures £20m Series A with GV, OSI and Sequoia China". Oxford University Innovation. https://innovation.ox.ac.uk/news/vaccitech-20m-series-a/.
- ↑ Anon (2019). "About Vaccitech". Vaccitech Limited. https://www.vaccitech.co.uk/about/.
- ↑ Boseley, Sarah (1 July 2020). "Oxford offers best hope for Covid-19 vaccine this year, MPs told". Guardian News & Media Limited. https://www.theguardian.com/world/2020/jul/01/oxford-offers-best-hope-for-a-covid-19-vaccine-this-year-mps-told.
 |
